Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04339998 · ClinicalTrials.gov registry record
Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)
A clinical trial of COVID-19 and SARS-CoV-2, sponsored by University of Minnesota.
- Completed
- Registry status
- 129
- Enrollment target
- 2
- Study locations
NCT04339998: Completed study of COVID-19 and SARS-CoV-2, sponsored by University of Minnesota.
NCT04339998 is a study of COVID-19 and SARS-CoV-2 that has completed, run by University of Minnesota. The registered enrollment target is 129 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04339998, a study of COVID-19 and SARS-CoV-2, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
- 2
- Study locations
Study Summary
Specific Aims: 1. The investigators will prospectively evaluate and analyze changes in the appearance of the lungs and heart through serial acquisition of focused point-of-care ultrasound images in a cohort of patients with or under investigation for COVID-19. 2. The investigators will correlate changes noted in ultrasound with clinical course and diagnostic evaluation to ascertain whether changes on ultrasound could improve care through earlier diagnosis or identification of patients at high risk of disease progression.
Primary Outcome
POCUS is a 6-point scale evaluating the degree of abnormalities and number of sites with abnormalities in ultrasound images of the lungs. Higher scores indicate greater malady. Pulmonary POCUS Evaluation: 1. B lines: absent (\< 3 lines), present (\> 3 lines), fused 2. Consolidation: yes or no a. Bilateral: yes or no 3. Pleural Effusion: yes or no 4. Other pleural abnormalities: yes or no Score each finding based on degree of abnormalities and number of sites with abnormalities
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point-of-Care Ultrasonography (POCUS)
Study Locations (2)
Minnesota
- University of Minnesota Medical Center (UMMC) - Minneapolis
- M Health Fairview Bethesda Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2020-10-01 |
What the finished NCT04339998 record still lists
NCT04339998 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Point-of-Care Ultrasonography (POCUS) is the first listed.
NCT04339998 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04339998 about?
NCT04339998 is a clinical study titled "Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)". Specific Aims: 1. The investigators will prospectively evaluate and analyze changes in the appearance of the lungs and heart through serial acquisition of focused point-of-care ultrasound images in a cohort of patients with or under investigation for COVID-19. 2. The investigators will correlate ch...
What is the current status of trial NCT04339998?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2020-04-15. Estimated completion is 2020-10-01.
What conditions does trial NCT04339998 study?
This clinical trial studies the following conditions: COVID-19, SARS-CoV-2, Corona Virus Infection, COVID.
What interventions are being tested in trial NCT04339998?
The interventions under investigation include: Point-of-Care Ultrasonography (POCUS) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04339998?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04339998 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04339998's enrollment target sits among peer trials
129 185th of 298 higher than 113 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI